Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bulent Erdogan

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 2, 2019
Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102Muhammet Bekir Hacioglu, Osman Kostek, Nazmi Kurt, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 14, 2023
Association between hyponatremia, inflammation, and mortality in patients undergoing peritoneal dialysis: A nationwide observationsBulent Erdogan, Naim Ata, Murat Caglayan, et al.
The Prostate|February 20, 2025
Prognostic Nutritional Index as a Biomarker in Metastatic Hormone-Sensitive Prostate Cancer: Impact on Survival and Treatment OptimizationMuhammet Bekir Hacioglu, Ahmet Kucukarda, Ivo Gokmen, et al.
World Journal of Urology|January 22, 2015
Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical OncologyAhmet Bilici, Turkan Ozturk, Esma Turkmen, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 28, 2014
Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncologyVeli Berk, Mehmet Ali Kaplan, Onder Tonyali, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2020
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from TurkeyMuhammet Bekir Hacioglu, Osman Kostek, Senem Karabulut, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|April 17, 2025
Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)Nargiz Majidova, Sendag Yaslıkaya, Maral Martin Mıldanoglu, et al.
Journal of Clinical Medicine|February 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective AnalysisBaris Koksal, Hasan Cagri Yildirim, Deniz Can Guven, et al.
Head & Neck|April 21, 2023
Major and minor salivary gland cancers: A multicenter retrospective studyMuhammet Bekir Hacioglu, Bulent Erdogan, Murat Bardakcı, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 2, 2019
Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102Muhammet Bekir Hacioglu, Osman Kostek, Nazmi Kurt, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 14, 2023
Association between hyponatremia, inflammation, and mortality in patients undergoing peritoneal dialysis: A nationwide observationsBulent Erdogan, Naim Ata, Murat Caglayan, et al.
The Prostate|February 20, 2025
Prognostic Nutritional Index as a Biomarker in Metastatic Hormone-Sensitive Prostate Cancer: Impact on Survival and Treatment OptimizationMuhammet Bekir Hacioglu, Ahmet Kucukarda, Ivo Gokmen, et al.
World Journal of Urology|January 22, 2015
Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical OncologyAhmet Bilici, Turkan Ozturk, Esma Turkmen, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 28, 2014
Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncologyVeli Berk, Mehmet Ali Kaplan, Onder Tonyali, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2020
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from TurkeyMuhammet Bekir Hacioglu, Osman Kostek, Senem Karabulut, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|April 17, 2025
Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)Nargiz Majidova, Sendag Yaslıkaya, Maral Martin Mıldanoglu, et al.
Journal of Clinical Medicine|February 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective AnalysisBaris Koksal, Hasan Cagri Yildirim, Deniz Can Guven, et al.
Head & Neck|April 21, 2023
Major and minor salivary gland cancers: A multicenter retrospective studyMuhammet Bekir Hacioglu, Bulent Erdogan, Murat Bardakcı, et al.
Pageof 9